Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

SAN FRANCISCO, September 8 /PRNewswire/ --

- Live Demo of mobiclip.com Beta for Windows Mobile and Symbian Phones Plus Preview of Live TV on Apple iPhone

Actimagine will demonstrate mobiclip.com, a web-to-mobile platform delivering high-definition video on mobile phones over any wireless network at the September CTIA exhibition.

Sign-up now or at the show for a free account on mobiclip.com to access videos on WinMobile and Symbian phones with just a few clicks. This includes live or on-demand news, sports, movies, entertainment, and more.

Live TV for iPhone will be demonstrated at Actimagine's booth, and made available through mobiclip.com for iPhone(TM) and iTouch(TM) users in the coming weeks.

BALTIMORE, September 8 /PRNewswire/ --

- Offering Achieves Global Recognition As Result of Rigorous Testing

RWD Technologies, a global company that develops and implements organizational performance solutions, today announced the newest version of its comprehensive performance support product that allows staff to collaboratively create, store and manage application simulations and procedural documentation, successfully completed SAP's Premium Qualification process. During the rigorous testing process, RWD uPerform(R) 3.0, met key criteria in a process that focused on 13 categories including usability, security, and functional correctness. The certification covers all RWD uPerform 3.0 versions globally.

REDMOND, Washington, September 8 /PRNewswire/ --

- Leading global brand turns to Windows Embedded NavReady 2009 to quickly bring customers smart, connected, service-oriented portable navigation devices.

Microsoft Corp. today announced that Mio Technology Corp., a leading producer of portable navigation devices (PNDs) with integrated Global Positioning Systems (GPSs), expanded its support of the Windows Embedded offerings and will be shipping its next-generation PNDs on the Windows Embedded NavReady 2009 platform.

(Logo: http://www.newscom.com/cgi-bin/prnh/20000822/MSFTLOGO)

ZURICH, Switzerland, September 8 /PRNewswire/ --

- Preclinical Pharmacokinetic Data to be Presented at the 7th International Symposium on Uveitis in Germany

LONDON, September 8 /PRNewswire/ -- Vagisil(R) are delighted to invite you to The WoW Show - a one-day event, run by Wellbeing of Women, focusing on women's gynaecological health issues at the Royal College of Obstetricians and Gynaecologists.

Bringing together the college's well-respected consultants and leading doctors in the field of gynaecology, The WoW Show gives you the chance to meet the experts and ask the questions you've always wanted to know the answers to.

When: Saturday 20th September 2008, 10.00 am to 4.00 pm Where: The Royal College of Obstetricians and Gynaecologists 27 Sussex Place, London NW1 4SP Visit the Vagisil(R) stand and collect samples. Attend educational seminars to help you dispel the myths surrounding women's health issues.

LONDON, September 8 /PRNewswire/ -- Myconostica, a UK-based medical diagnostic company which specialises in rapid and highly specific tests for life-threatening fungal infections, today announces the launch of a new test to assist medical and scientific professionals identify the two most common causes of fungal pneumonia. The assay, FXGTM: RESP (Asp +), uses Real-Time PCR technology to accurately and rapidly identify infections caused by both Aspergillus and Pneumocystis.

Key Points:

- Fungal pneumonia is the leading cause of infectious death in leukaemia and bone marrow transplant patients and is the most common first manifestation of AIDS.